Iwata, Hiroji http://orcid.org/0000-0002-0242-4718
Masuda, Norikazu
Yamamoto, Yutaka
Fujisawa, Tomomi
Toyama, Tatsuya
Kashiwaba, Masahiro
Ohtani, Shoichiro
Taira, Naruto
Sakai, Takehiko
Hasegawa, Yoshie
Nakamura, Rikiya
Akabane, Hiromitsu
Shibahara, Yukiko
Sasano, Hironobu
Yamaguchi, Takuhiro
Sakamaki, Kentaro
Bailey, Helen
Cherbavaz, Diana B.
Jakubowski, Debbie M.
Sugiyama, Naoko
Chao, Calvin
Ohashi, Yasuo
Article History
Received: 27 July 2018
Accepted: 6 September 2018
First Online: 21 September 2018
Compliance with ethical standards
:
: Hiroji Iwata: Remuneration: AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Genomic Health, Novartis, Pfizer, Taiho. Consultant/advisory role: AstraZeneca, Chugai, Daiichi-Sankyo, Kyowa Hakko Kirin, Lilly, Novartis, Pfizer. Funding: AstraZeneca, Bayer, Chugai, Daiichi-Sankyo, Eisai, GSK, Kyowa Hakko Kirin, Lily, MSD, Novartis, Pfizer. Other: CSPOR BC organizing committee member. Norikazu Masuda: Remuneration: AstraZeneca, Chugai, Pfizer, Takeda. Funding to institution: AstraZeneca, Chugai, Daiichi-Sankyo, Kyowa Hakko Kirin, Lilly, MSD, Novartis, Pfizer. Yutaka Yamamoto: Remuneration: AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Genomic Health, Kyowa Hakko Kirin, Novartis, Pfizer, Taiho, Takeda. Funding: AstraZeneca, Chugai, Novartis, Taiho. Tatsuya Toyama: Remuneration: AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Ono Pharmaceutical, Taiho, Takeda. Funding: AstraZeneca, Chugai, Daiichi-Sankyo, Eisai, Kyowa Hakko Kirin, Nippon Kiyaku, Novartis, Pfizer, Taiho, Takeda. Masahiro Kashiwaba: Remuneration: AstraZeneca, Chugai, Kyowa Hakko Kirin, Novartis, Pfizer. Shoichiro Ohtani: Remuneration: Chugai, Eisai. Tomomi Fujisawa, Naruto Taira, Takehiko Sakai, Yoshie Hasegawa, Rikiya Nakamura, Hiromitsu Akabane, Yukiko Shibahara, and Hironobu Sasano: None. Takuhiro Yamaguchi: Remuneration: Daiichi-Sankyo. Consulting or advisory role: CAC Croit Corporation, Chugai, Daiichi-Sankyo, Japan Tobacco, Kowa Company, Ono Pharmaceutical, Tsumura & Co. Funding: A2 Healthcare Corporation, AC Medical Inc., CAC Croit Corporation, Daiichi-Sankyo, FMD K&L Japan K.K., Japan Media Corporation, Japan Tobacco Inc., Kyowa Hakko Kirin, Luminary Medical K.K., Medidata Solutions, Inc., Ono Pharmaceutical. Kentaro Sakamaki: Remuneration: Chugai, Novartis, Taiho. Travel expenses: Genomic Health. Helen Bailey: Employment and stock ownership: Genomic Health. Diana B. Cherbavaz: Stock ownership: Genomic Health. Debbie M. Jakubowski: Employment and stock ownership: Genomic Health. Naoko Sugiyama: Employment and stock ownership: Genomic Health. Calvin Chao: Employment and stock ownership: Genomic Health. Yasuo Ohashi: Remuneration: Daiichi-Sankyo, Eisai, Public Health Research Foundation, Sanofi. Research grant: Eisai. Consultant/advisory role: Chugai, Kowa, Taiho. Travel expenses: Takeda, Yakult Honsha. Other: Shionogi, Statcom.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was reviewed and approved by each institution’s review board and/or ethics committee.
: Informed consent was obtained from all individual participants included in the study.